MetaCap

Faeth Therapeutics Inc. Company Profile

NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.88-0.81 (-9.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Faeth Therapeutics at a glance

Faeth Therapeutics Inc. (NASDAQ: FTH) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Rockville, MD. Faeth Therapeutics is led by Mr. Anand Parikh Esq., J.D. and employs about 29 people. The company's shares have traded publicly since 2021.

At a market capitalization of $203.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001829802, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Faeth Therapeutics do?

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. The company was formerly known as Sensei Biotherapeutics, Inc. and changed its name to Faeth Therapeutics, Inc. in June 2026. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.

Business description based on the company's public filings.

Company information

Legal name
Faeth Therapeutics Inc.
Ticker
NASDAQ: FTH
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Anand Parikh Esq., J.D.
Employees
29
Headquarters
1405 Research Boulevard, Rockville, MD, United States
Phone
240 243 8000
IPO year
2021
Market cap
$203.65M
SEC CIK
0001829802
Latest annual report
10-K/A · Jun 2, 2026

Companies similar to Faeth Therapeutics

FTH peer companies
CompanyPrice% ChgMarket capCompare
BCYCBicycle Therapeutics plc ADR2.90-4.92%$203.27Mvs FTH
DRUGBright Minds Biosciences Inc.20.40-1.45%$201.23Mvs FTH
VNDAVanda Pharmaceuticals Inc.3.45-6.13%$208.32Mvs FTH
NGENNervGen Pharma Corp.1.85-3.91%$198.55Mvs FTH
CYPHCypherpunk Technologies Inc.1.41-18.02%$210.15Mvs FTH
BIOABioAge Labs Inc.4.28-9.13%$196.67Mvs FTH
YARWYarrow Bioscience Inc.12.90-9.35%$196.53Mvs FTH
ACIUAC Immune SA1.95-8.45%$193.88Mvs FTH

Related